| Primary |
| Hypertonic Bladder |
29.2% |
| Hypertension |
11.3% |
| Depression |
8.5% |
| Type 2 Diabetes Mellitus |
5.2% |
| Pain |
4.7% |
| Anxiety |
4.2% |
| Anaemia |
3.8% |
| Diabetes Mellitus |
3.8% |
| Prophylaxis |
3.3% |
| Coronary Artery Disease |
2.8% |
| Myocardial Ischaemia |
2.8% |
| Supplementation Therapy |
2.8% |
| Benign Prostatic Hyperplasia |
2.4% |
| Blood Cholesterol Increased |
2.4% |
| Insomnia |
2.4% |
| Osteoporosis |
2.4% |
| Pollakiuria |
2.4% |
| Bladder Disorder |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Hyperlipidaemia |
1.9% |
|
| Syncope |
11.1% |
| Left Ventricular Failure |
9.5% |
| Throat Tightness |
9.5% |
| Transient Ischaemic Attack |
9.5% |
| Colitis Ischaemic |
6.3% |
| Pyelonephritis Acute |
6.3% |
| Death |
4.8% |
| Gastritis |
4.8% |
| Hypertension |
4.8% |
| Oedema Peripheral |
4.8% |
| Overdose |
4.8% |
| Palpitations |
3.2% |
| Pruritus |
3.2% |
| Renal Failure |
3.2% |
| Renal Failure Acute |
3.2% |
| Spinal Operation |
3.2% |
| Urinary Retention |
3.2% |
| Abdominal Pain Upper |
1.6% |
| Cerebellar Infarction |
1.6% |
| Chest Pain |
1.6% |
|
| Secondary |
| Hypertonic Bladder |
15.4% |
| Product Used For Unknown Indication |
14.1% |
| Drug Use For Unknown Indication |
12.8% |
| Hypertension |
11.5% |
| Urinary Incontinence |
7.7% |
| Diabetes Mellitus |
5.1% |
| Hypercholesterolaemia |
3.8% |
| Pollakiuria |
3.8% |
| Urge Incontinence |
3.8% |
| Dementia |
2.6% |
| Depression |
2.6% |
| Glaucoma |
2.6% |
| Oedema Peripheral |
2.6% |
| Pain In Extremity |
2.6% |
| Prophylaxis |
2.6% |
| Alzheimer's Disease |
1.3% |
| Analgesic Therapy |
1.3% |
| Antipyresis |
1.3% |
| Arthritis |
1.3% |
| Bladder Disorder |
1.3% |
|
| Pyelonephritis Acute |
10.7% |
| Dizziness |
7.1% |
| Drug Ineffective |
7.1% |
| Dysuria |
7.1% |
| Memory Impairment |
7.1% |
| Oedema Peripheral |
7.1% |
| Syncope |
7.1% |
| Throat Tightness |
7.1% |
| Blood Pressure Increased |
3.6% |
| Myocarditis |
3.6% |
| Nausea |
3.6% |
| Off Label Use |
3.6% |
| Panic Reaction |
3.6% |
| Skin Disorder |
3.6% |
| Systemic Lupus Erythematosus |
3.6% |
| Urinary Retention |
3.6% |
| Vision Blurred |
3.6% |
| Vomiting |
3.6% |
| Walking Aid User |
3.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
17.5% |
| Drug Use For Unknown Indication |
7.8% |
| Atrial Fibrillation |
7.1% |
| Hypertension |
7.1% |
| Pain |
5.8% |
| Type 2 Diabetes Mellitus |
5.8% |
| Diabetes Mellitus |
5.2% |
| Multiple Sclerosis |
5.2% |
| Benign Prostatic Hyperplasia |
3.9% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
3.9% |
| Osteoporosis |
3.9% |
| Urinary Incontinence |
3.9% |
| Constipation |
3.2% |
| Contraception |
3.2% |
| Prophylaxis |
3.2% |
| Analgesic Therapy |
2.6% |
| Bladder Disorder |
2.6% |
| Blood Oestrogen Decreased |
2.6% |
| Blood Pressure |
2.6% |
| Fluid Retention |
2.6% |
|
| Gastroenteritis Cryptosporidial |
9.7% |
| Polyneuropathy |
9.7% |
| Asthenia |
6.5% |
| Death |
6.5% |
| Drug Ineffective |
6.5% |
| Lower Limb Fracture |
6.5% |
| Placenta Praevia Haemorrhage |
6.5% |
| Renal Failure Chronic |
6.5% |
| Tremor |
6.5% |
| Amenorrhoea |
3.2% |
| Angina Pectoris |
3.2% |
| Blood Creatine Phosphokinase Increased |
3.2% |
| Breast Cancer Female |
3.2% |
| Cardiac Arrest |
3.2% |
| Cluster Headache |
3.2% |
| Coronary Artery Disease |
3.2% |
| Eye Disorder |
3.2% |
| Femoral Artery Occlusion |
3.2% |
| Haemorrhage |
3.2% |
| Haemorrhage Urinary Tract |
3.2% |
|
